Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Obscure User Fee Provision Gives Generic Drug Sponsors More Time To Pay Fees Post-Shutdown
Nov 25 2025
•
By
Derrick Gingery
The FDA gave ANDA sponsors a longer time to pay fees for applications submitted during the shutdown.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from United States